⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ENTX News
Entera Bio Ltd. Ordinary Shares
Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates
globenewswire.com
ENTX
Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women
globenewswire.com
ENTX
Entera Bio to Present New Clinical Data from Phase 2 Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting
globenewswire.com
ENTX